These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 8464648)
21. [Therapeutic effects of cefprozil in the treatment of various infectious diseases in children]. Wakiguchi H; Ohishi N; Kido S; Takechi T; Takeda K; Yoshimura K; Nomura I; Fujieda M; Araki K; Kurashige T Jpn J Antibiot; 1992 Dec; 45(12):1676-83. PubMed ID: 1289587 [TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field]. Motohiro T; Aramaki M; Oda K; Kawakami A; Koga T; Tomita S; Sakata Y; Yamashita F; Takajo N; Okabayashi S Jpn J Antibiot; 1992 Dec; 45(12):1700-35. PubMed ID: 1289589 [TBL] [Abstract][Full Text] [Related]
23. Cefdinir: an expanded-spectrum oral cephalosporin. Guay DR Ann Pharmacother; 2000 Dec; 34(12):1469-77. PubMed ID: 11144705 [TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of a new oral cephalosporin, cefprozil, in pediatrics]. Woo M; Higashino H; Kohdera U; Nakamura M; Kawasaki H; Kino M; Kobayashi Y Jpn J Antibiot; 1992 Dec; 45(12):1635-41. PubMed ID: 1289581 [TBL] [Abstract][Full Text] [Related]
25. Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Barradell LB; Bryson HM Drugs; 1994 Mar; 47(3):471-505. PubMed ID: 7514976 [TBL] [Abstract][Full Text] [Related]
26. The cephalosporin antibiotics in pediatric practice. Ross S; Rodriguez W; Khan W South Med J; 1977 Jul; 70(7):855-61. PubMed ID: 877649 [TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis. McCarty JM Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):846-50. PubMed ID: 7889958 [TBL] [Abstract][Full Text] [Related]
28. Cefpodoxime proxetil: a review of its use in the management of bacterial infections in paediatric patients. Fulton B; Perry CM Paediatr Drugs; 2001; 3(2):137-58. PubMed ID: 11269640 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the efficacy and tolerability of once-daily ceftibuten and twice-daily cefprozil in the treatment of children with acute otitis media. Blumer JL; Forti WP; Summerhouse TL Clin Ther; 1996; 18(5):811-20. PubMed ID: 8930425 [TBL] [Abstract][Full Text] [Related]
30. Redefining the management of pediatric tonsillopharyngitis with cefprozil. Jerath N; Shetty G Indian J Pediatr; 2007 Dec; 74(12):1105-8. PubMed ID: 18174646 [TBL] [Abstract][Full Text] [Related]
31. Summary: role of a new oral cephalosporin, cefdinir, for therapy of infections of infants and children. Klein JO; McCracken GH Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S181-3. PubMed ID: 11144402 [No Abstract] [Full Text] [Related]
32. [Review of oral cephalosporins. Basis for a rational choice]. Forti IN Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980 [TBL] [Abstract][Full Text] [Related]
37. The management of bacterial infections of the upper respiratory tract in children: pharyngitis and otitis media. Adam D Manag Care Interface; 2000 Apr; 13(4):83-8. PubMed ID: 11066289 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of new oral antimicrobial agents and the experience with cefprozil--a broad-spectrum oral cephalosporin. Klein JO Clin Infect Dis; 1992 Jun; 14 Suppl 2():S183. PubMed ID: 1617035 [No Abstract] [Full Text] [Related]
39. [Preliminary clinico-therapeutic trials of new cephalosporin: cefotaxime]. Frongillo RF; Galuppo L; Dominici C Clin Ter; 1981 Jul; 98(1):25-35. PubMed ID: 6265143 [No Abstract] [Full Text] [Related]
40. [Clinical evaluation of cefprozil in children]. Mochizuki Y; Kanazashi S; Hata D; Ohkubo H; Itoh S; Mayumi M; Mikawa H Jpn J Antibiot; 1992 Dec; 45(12):1622-34. PubMed ID: 1289580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]